
CD200 is induced by ERK and is a potential therapeutic target in melanoma
Author(s) -
Kimberly B. Petermann,
Gabriela I. Rozenberg,
Daniel C. Zedek,
Pamela A. Groben,
Karen P. McKin,
Christin Buehler,
William Y. Kim,
Janiel M. Shields,
Shan Penland,
James E. Bear,
Nancy E. Thomas,
Jonathan S. Serody,
Norman E. Sharpless
Publication year - 2007
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/17rv-0x14
Subject(s) - melanoma , mapk/erk pathway , psychology , medicine , cancer research , biology , microbiology and biotechnology , kinase